CPRX

NASDAQ · Biotechnology

Catalyst Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$31.49

+0.01 (+0.03%)

As of Oct 31, 1:36 AM ET ·

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 6 67%

Sell 3 33%

Price Target

Analyst Price Target +59.2% upside

Low Target $36.48

Average Target $50.13

High Target $69.47

Current Price $31.49

Current
$31.49

Target
$50.13

$36.48 $50.13 avg $69.47

Scenario Analysis

Bear Case

$36.48

15.8%

Low target

Base Case

$50.13

+59.2%

Avg target

Bull Case

$69.47

+120.6%

High target

Risk/Reward

7.6x

Highly favorable

Price in Context

52-Week High

$32.56

-3.3% from high

52-Week Low

$20.66

+52.4% from low

50-Day SMA

$28.16

+11.8% vs SMA

200-Day SMA

$23.83

+32.1% vs SMA

RSI (14)

65.0

Neutral

Target vs 52W High

$50.13

+54.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%